Jubilant Pharmova Ltd announced that ICRA Limited has assigned ratings of [ICRA]AA+ (Stable) to its proposed Non-Convertible Debentures amounting to 1,400.00, referencing ICRA/Jubilant Pharmova Limited/13102026/1 dated October 13, 2026, and also assigned a rating of [ICRA]AA+(Stable) to its Non-convertible Debenture Programme amounting to 1,400.00, with the rating valid throughout the life of the programme and subject to SEBI's grievance redressal mechanisms, with no enhancements, assignments, or withdrawals noted by either agency.
